Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 38, 2012 - Issue 8
Submit an article Journal homepage
134
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Acid-base catalysis of N-[(morpholine)methylene]daunorubicin

Anna KrausePozLab Sp z o.o., Parcowa, Poznań, Poland
,
Anna JelińskaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka, Poznan, Poland
,
Judyta Cielecka-PiontekDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka, Poznan, Poland
,
Maria KlawitterDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka, Poznan, Poland
,
Przemysław ZalewskiDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka, Poznan, PolandCorrespondence[email protected]
,
Irena OszczapowiczDepartment of Modified Antibiotics, Institute of Biotechnology and Antibiotics, Staroscinska, Warsaw, Poland
&
Małgorzata WąsowskaDepartment of Modified Antibiotics, Institute of Biotechnology and Antibiotics, Staroscinska, Warsaw, Poland
 show all
Pages 1024-1028 | Received 17 Aug 2011, Accepted 27 Oct 2011, Published online: 29 Nov 2011

References

  • Arcamone F, Animati F, Capranico G, Lombardi P, Pratesi G, Manzini S et al. (1997). New developments in antitumor anthracyclines. Pharmacol Ther, 76:117–124.
  • Hortobágyi GN. (1997). Anthracyclines in the treatment of cancer. An overview. Drugs, 54 Suppl 4:1–7.
  • Wasowska M, Wietrzyk J, Opolski A, Oszczapowicz J, Oszczapowicz I. (2006). Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells. Anticancer Res, 26:2009–2012.
  • Wasowska M, Oszczapowicz I, Wietrzyk J, Opolski A, Madej J, Dzimira S et al. (2005). Influence of the structure of new anthracycline antibiotics on their biological properties. Anticancer Res, 25:2043–2048.
  • Ciesielska E, Studzian K, Wasowska M, Oszczapowicz I, Szmigiero L. (2005). Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety. Cell Biol Toxicol, 21:139–147.
  • Opolski A, Wąsowska M, Wietrzyk J, Nasulewicz A, Oszczapowicz I, Oszczapowicz J. 14th EORTCNCI-AACr symposium on molecular target and cancer therapeutics, Frankfurt, Germany, 2002.
  • Beijnen JH, van der Houwen OA, Voskuilen MC, Underberg WJ. (1986). Aspects of the degradation kinetics of daunorubicin in aqueous solution. Int J Pharm, 1:75–82.
  • Poochikian GK, Cradock JC, Flora KP. (1981). Stability of anthracycline antitumor agents in four infusion fluids. Am J Hosp Pharm, 38:483–486.
  • Karlsen J, Thonnensen H, Resberg O, Horne S, Skobba TJ. (1983). Stability of anthracycline antitumour agents in four infusion fluids. Norw Pharm Act, 45:61–67.
  • Cielecka-Piontek J, Jelinska A, Zajac M, Sobczak M, Bartold A, Oszczapowicz I. (2009). A comparison of the stability of doxorubicin and daunorubicin in solid state. J Pharm Biomed Anal, 50:576–579.
  • Zalewski P, Jelinska A, Prusinowska P, Cielecka-Piontek J, Krause A, Oszczapowicz I. (2011). Stability of [(N-morpholine)metylene]daunorubicin hydrochloride in solid state. Acta Pol Pharm, 68:759–763.
  • Zalewski P, Zając M, Jelińska A, Cielecka-Piontek J, Oszczapowicz I. (2011). Stability study of anticancer agent N-[(Hexahydroazepin-1-yl)methyl]daunorubicin in aqueous solutions using HPLC method. Asian J Chem, 23:835–838.
  • Jelińska A, Uszak J, Cielecka-Piontek J, Zając M, Lamberti A, Oszczapowicz I, Wąsowska M. (2009). Stability of [(N-pyrrolidine)metylene]daunorubicin in aqueous solutions. React Kinet Catal Lett, 98:69–75.
  • Cielecka-Piontek J, Jelińska A, Dołhań A, Zalewski P, Burek D, Piekarski M, Krause A, Uszak J, Oszczapowicz I, Łukawska M. (2012). Stability of new anticancer agents in intravenous solutions. Asian J Chem, 24:769–772.
  • Łukawska M, Oszczapowicz I, Jelińska A, Cielecka-Piontek J, Zając M, Dobrowolski L, Ziółkowska G, Zalewski P, Piekarski M, Krause A, Uszak J. (2009). Development and validation of RP-HPLC method for determination of novel derivatives of daunorubicin. Chem Anal, 54:907–917.
  • Jelińska A, Zając M, Cielecka-Piontek J, Głąb K, Tomaszewicz B, Krause A, Oszczapowicz I, Wąsowska M. (2008). Validation of a stability indicating LC-UV method for [(N-Morpholine)methylene]daunorubicin hydrochloride. Chromatographia, 67:107–111.
  • Wąsowska M, Oszczapowicz J, Oszczapowicz I, Owoc A. (2006). Patent C07H 15/252.
  • Pawełczyk E, Hermann T. (1982). The fundamentals of stability of drugs (in polish). Warsaw: PZWL Poland.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.